Literature DB >> 32424891

Opportunistic virus infections in psoriasis patients: The safer alternative of apremilast in the COVID-19 era.

Susana Armesto1, Carmen González Vela2, Marco Antonio González López1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32424891     DOI： 10.1111/dth.13618

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  2 in total

Review 1.  Apremilast in Paediatric Dermatoses - A Comprehensive Review.

Authors:  Nibedita Patro; Maitreyee Panda; Mrityunjay Dash; Anupam Das
Journal:  Indian J Dermatol       Date:  2022 Mar-Apr       Impact factor: 1.757

2.  COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain.

Authors:  Rubén Queiro Silva; Susana Armesto; Carmen González Vela; Cristina Naharro Fernández; Miguel Angel González-Gay
Journal:  Dermatol Ther       Date:  2020-07-27       Impact factor: 3.858
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.